Advanced

Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden

Norlin, Jenny M.; Steen Carlsson, Katarina LU ; Persson, Ulf LU and Schmitt-Egenolf, Marcus (2015) In Acta Dermato-Venereologica 95(2). p.156-161
Abstract
The introduction of biologics has changed treatment patterns as well as costs in patients with psoriasis. This study was performed to estimate direct and indirect costs of the psoriasis population in Sweden, and to analyse changes in costs between 2006 and 2009. The study population was identified in national registers. Direct costs included health care visits with primary psoriasis diagnoses in specialist care and drugs relevant for treating psoriasis. Productivity loss, including costs of long-term sick leave and disability pension, was estimated as the difference between psoriasis patients and matched controls from the general population. Total direct cost increased from SEK 348 million (similar to(sic)39) in 2006 to SEK 459 million... (More)
The introduction of biologics has changed treatment patterns as well as costs in patients with psoriasis. This study was performed to estimate direct and indirect costs of the psoriasis population in Sweden, and to analyse changes in costs between 2006 and 2009. The study population was identified in national registers. Direct costs included health care visits with primary psoriasis diagnoses in specialist care and drugs relevant for treating psoriasis. Productivity loss, including costs of long-term sick leave and disability pension, was estimated as the difference between psoriasis patients and matched controls from the general population. Total direct cost increased from SEK 348 million (similar to(sic)39) in 2006 to SEK 459 million (similar to(sic)51) in 2009, whereas the total productivity loss decreased from SEK 1,646 (similar to(sic)183) to 1,618 million (similar to(sic)180) between 2006 and 2009. Although direct costs, especially for biologic agents, have increased for patients with psoriasis over time, this study indicates that costs related to productivity loss are still more substantial. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
psoriasis, cost of illness, productivity loss, biologics
in
Acta Dermato-Venereologica
volume
95
issue
2
pages
156 - 161
publisher
Medical Journals Limited
external identifiers
  • wos:000349270900007
  • scopus:84928235405
ISSN
1651-2057
DOI
10.2340/00015555-1895
language
English
LU publication?
yes
id
c63afe3a-5ffa-462c-8b3b-9b12fff194c6 (old id 5194581)
date added to LUP
2015-04-01 07:33:58
date last changed
2017-04-02 04:16:38
@article{c63afe3a-5ffa-462c-8b3b-9b12fff194c6,
  abstract     = {The introduction of biologics has changed treatment patterns as well as costs in patients with psoriasis. This study was performed to estimate direct and indirect costs of the psoriasis population in Sweden, and to analyse changes in costs between 2006 and 2009. The study population was identified in national registers. Direct costs included health care visits with primary psoriasis diagnoses in specialist care and drugs relevant for treating psoriasis. Productivity loss, including costs of long-term sick leave and disability pension, was estimated as the difference between psoriasis patients and matched controls from the general population. Total direct cost increased from SEK 348 million (similar to(sic)39) in 2006 to SEK 459 million (similar to(sic)51) in 2009, whereas the total productivity loss decreased from SEK 1,646 (similar to(sic)183) to 1,618 million (similar to(sic)180) between 2006 and 2009. Although direct costs, especially for biologic agents, have increased for patients with psoriasis over time, this study indicates that costs related to productivity loss are still more substantial.},
  author       = {Norlin, Jenny M. and Steen Carlsson, Katarina and Persson, Ulf and Schmitt-Egenolf, Marcus},
  issn         = {1651-2057},
  keyword      = {psoriasis,cost of illness,productivity loss,biologics},
  language     = {eng},
  number       = {2},
  pages        = {156--161},
  publisher    = {Medical Journals Limited},
  series       = {Acta Dermato-Venereologica},
  title        = {Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden},
  url          = {http://dx.doi.org/10.2340/00015555-1895},
  volume       = {95},
  year         = {2015},
}